الفهرس 
ObesityOnly 14 pages are availabe for public view
 |  | from | 278 |  |  |
| | | from | 278 | | |
Abstract
Background: Obesity has become a worldwide pandemic health problem, and morbid obesity leads to a high rate of complications associated with metabolic syndrome, including type 2 diabetes mellitus (DM).The majority of morbidly obese diabetic patients display a dramatic improvement in their type 2 diabetes mellitus (T2DM), and this group benefits the most from bariatric surgery. For this reason, bariatric surgery , especially sleeve gastrectomy and minigastric bypass which are the most common bariatric surgery done nowadays, has been proposed as a new treatment modality for obese diabetic patients who do not have satisfactory control with current medical treatment. Method: It is a randomized controlled study which was done between December 2014 – December 2016 at Ain Shams university hospitals, Cairo, Egypt. This study included 60 obese patients with type 2 D.M and randomly divided using closed envelopment method into two groups group (1): (30 patients) treated by laparoscopic Sleeve gastrectomy and group (2): (30 patients) treated by laparoscopic Mini-Gastric Bypass. Result: Both operation were effective in remission of D.M with the better effect was in group 2 (minigastric bypass) reflected by resolved cases was 80% in MGB and 66.7% in SG at 12 months and cases with no remission in D.M was 0% in MGB and 6.7% with SG and the effect of MGB was faster and earlier than SG reflected by cases with early diabetes resolution at 6 months was 46.7% with MGB in comparison to 20% with SG. Conclusion: Bariatric surgery (SG and MGB) is not only weight reducing surgery but a metabolic surgery which can cure most of the metabolic syndrome and they are considered the most effective long term treatment modality for type 2 diabetes in obese patients and with comparing between SG and MGB, our study suggests that MGB has better and earlier effect than SG in diabetes remission.